Connect with us
In 2024, Spain’s pharmaceutical industry surpassed €1.5 billion in R&D investment, emphasizing clinical research and collaborations beyond universities. Nearly 45% of projects involve hospitals and research...
If you missed the boat on Groupon's recent mega gains, then I've got good news. Giftify [NASDAQ: GIFT] has been quietly replicating the same winning formula...
Verb Technology is sitting on a pile of cash, has exploding revenues that are showing no signs of slowing down (in fact, they're accelerating), and it...
InnoCan Pharma's new Mexican patent for its fast-acting CBD pain gel marks a promising step into Latin America. Despite clinical promise, its stock remains low, down...
Cathie Wood’s Ark Invest surprised markets by investing $9.4M in eToro and $7.6M in a Solana ETF, while reducing its Bitcoin ETF stake by $7.9M. This...
The Dow Jones closed just shy of “scoring position,” a bullish zone from which all-time highs often emerge. Since 1885, 25.99% of its trading days have...
Inflation came in slightly below expectations, but remains above the Fed’s 2% target. Core rates are higher due to falling energy prices. Rate cuts in 2025...
Want one good reason for why you should read on? Here's one. There's major affiliate money to be made in an exploding niche, and we're going...
Canadians are shifting from traditional banks to crypto platforms like NDAX due to outdated systems, restricted crypto access, hidden fees, and limited control. These modern platforms...
Revo Foods launched a crowdfunding campaign on FunderNation, raising €1.2 million to expand its plant-based protein business. Despite market challenges, the company aims to boost appeal...